ICOPMAP SPECIAL EDITION Quercetin as an anti-hypertensive: A comprehensive review of the activity of quercetin compounds against Angiotensin Converting Enzyme (ACE) studies
DOI:
https://doi.org/10.46542/pe.2025.252.137146Keywords:
ACE-inhibitor, Blood pressure, Hypertension, QuercetinAbstract
Introduction: Hypertension represents one of the leading global health challenges. The target therapy available for treatment is Angiotensin Converting Enzyme Inhibitors (ACEI). Quercetin is an ACE inhibitor that is used as an anti-hypertensive.
Objective: This review article aims to study quercetin compounds and their bioactivity as antihypertensives, as well as the development of natural compounds that can be selective against specified target proteins (ACE) and can minimise the possibility of adverse side effects.
Methods: This study was conducted through a narrative review, collecting journals related to the topics discussed from PubMed, Google Scholar, Scopus, and ScienceDirect, spanning the period from 2010 to 2023.
Results: Quercetin has the ability to lower blood pressure by forming nitric oxide, which dilates blood vessels. This study also showed that inhibition can affect the activity of angiotensin-converting enzyme (ACE).
Discussion: According to the study, Quercetin has the potential to have pharmacological activity as an antihypertensive because its binding energy is more negative than the target protein's native ligand (lisinopril). This also indicates that quercetin can form more stable bonds than the standard compound (lisinopril), allowing it to act as an ACE inhibitor.
Conclusion: Quercetin has potential as an anti-hypertensive with an enzyme-inhibiting mechanism (ACE inhibitor).
References
Amadi, P. U., Agomuo, E. N., & Adumekwe, C. W. (2020). Modulatory properties of cardiac and quercetin glycosides from Dacryodes edulis seeds during L-NAME-induced vascular perturbation. Journal of basic and clinical physiology and pharmacology, 31(5). https://doi.org/10.1515/jbcpp-2019-0116
Asiedu-Gyekye, I. J., Edem Kukuia, K. K., Seidu, A. M., Antwi-Boasiako, C., N'guessan, B. B., Frimpong-Manso, S., Adjei, S., Zobi, J., Tettey, A. T., & Nyarko, A. K. (2016). Unsweetened natural cocoa powder has the potential to attenuate high dose artemether-lumefantrine-induced hepatotoxicity in non-malarious guinea pigs. Evidence-based complementary and alternative medicine: eCAM, 2016, 7387286. https://doi.org/10.1155/2016/7387286
Balasuriya, B. N., & Rupasinghe, H. V. (2011). Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Functional foods in health and disease, 1(5), 172‒188.
Balasuriya, N., & Rupasinghe, H. P. (2012). Antihypertensive properties of flavonoid-rich apple peel extract. Food chemistry, 135(4), 2320–2325. https://doi.org/10.1016/j.foodchem.2012.07.023
Burak, C., Brüll, V., Langguth, P., Zimmermann, B. F., Stoffel-Wagner, B., Sausen, U., Stehle, P., Wolffram, S., & Egert, S. (2017). Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. European journal of nutrition, 56(1), 343–353. https://doi.org/10.1007/s00394-015-1084-x
Ciocoiu, M., Badescu, L., Miron, A., & Badescu, M. (2013). The involvement of a polyphenol-rich extract of black chokeberry in oxidative stress on experimental arterial hypertension. Evidence-based complementary and alternative medicine: eCAM, 2013, 912769. https://doi.org/10.1155/2013/912769
Dabeek, W. M., & Marra, M. V. (2019). Dietary quercetin and kaempferol: Bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients, 11(10), 2288. https://doi.org/10.3390/nu11102288
Daskaya-Dikmen, C., Yucetepe, A., Karbancioglu-Guler, F., Daskaya, H., & Ozcelik, B. (2017). Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Plants. Nutrients, 9(4), 316. https://doi.org/10.3390/nu9040316
de Jesús Romero-Prado, M. M., Curiel-Beltrán, J. A., Miramontes-Espino, M. V., Cardona-Muñoz, E. G., Rios-Arellano, A., & Balam-Salazar, L. B. (2015). Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure. Basic & clinical pharmacology & toxicology, 117(1), 57–64. https://doi.org/10.1111/bcpt.12360
D'Elia L. (2018). Salt-sensitivity of blood pressure: Is it time to customize the antihypertensive therapy? American journal of hypertension, 31(7), 772–773. https://doi.org/10.1093/ajh/hpy056
Friedenreich, C. M., Langley, A. R., Speidel, T. P., Lau, D. C., Courneya, K. S., Csizmadi, I., Magliocco, A. M., Yasui, Y., & Cook, L. S. (2013). Case-control study of inflammatory markers and the risk of endometrial cancer. European Journal of Cancer Prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), 22(4), 374–379. https://doi.org/10.1097/CEJ.0b013e32835b3813
Fukai, T., & Ushio-Fukai, M. (2011). Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants & redox signaling, 15(6), 1583–1606. https://doi.org/10.1089/ars.2011.3999
Gomez, C., Berteina-Raboin, S., De Nanteuil, G., & Guillaumet, G. (2013). Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors. Bioorganic & medicinal chemistry, 21(22), 7216–7221. https://doi.org/10.1016/j.bmc.2013.08.032
Grassi, D., Desideri, G., Di Giosia, P., De Feo, M., Fellini, E., Cheli, P., Ferri, L., & Ferri, C. (2013). Tea, flavonoids, and cardiovascular health: Endothelial protection. The American journal of clinical nutrition, 98(6 Suppl), 1660S–1666S. https://doi.org/10.3945/ajcn.113.058313
Häkkinen, S. H., Kärenlampi, S. O., Heinonen, I. M., Mykkänen, H. M., & Törrönen, A. R. (1999). Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. Journal of agricultural and food chemistry, 47(6), 2274–2279. https://doi.org/10.1021/jf9811065
Harding, S. V., Rideout, T. C., & Jones, P. J. (2012). Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk. Journal of dietary supplements, 9(2), 116–127. https://doi.org/10.3109/19390211.2012.683136
Herman, L. L., Padala, S. A., Ahmed, I., & Bashir, K. (2023). Angiotensin Converting Enzyme Inhibitors (ACEI). In StatPearls. StatPearls Publishing.
Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A., Cohn, J. S., Rimm, E. B., & Cassidy, A. (2012). Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. The American Journal of Clinical Nutrition, 95(3), 740–751. https://doi.org/10.3945/ajcn.111.023457
Kafoud, A., Salahuddin, Z., Ibrahim, R. S., Al-Janahi, R., Mazurakova, A., Kubatka, P., & Büsselberg, D. (2023). Potential treatment options for neuroblastoma with polyphenols through anti-proliferative and apoptotic mechanisms. Biomolecules, 13(3), 563. https://doi.org/10.3390/biom13030563
Kalantari, H., Foruozandeh, H., Khodayar, M. J., Siahpoosh, A., Saki, N., & Kheradmand, P. (2017). Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice. Journal of traditional and complementary medicine, 8(1), 120–127. https://doi.org/10.1016/j.jtcme.2017.04.010
Kashino, Y., Murota, K., Matsuda, N., Tomotake, M., Hamano, T., Mukai, R., & Terao, J. (2015). Effect of processed onions on the plasma concentration of quercetin in rats and humans. Journal of food science, 80(11), H2597–H2602. https://doi.org/10.1111/1750-3841.13079
Kaushik, D., O'Fallon, K., Clarkson, P. M., Dunne, C. P., Conca, K. R., & Michniak-Kohn, B. (2012). Comparison of quercetin pharmacokinetics following oral supplementation in humans. Journal of food science, 77(11), H231–H238. https://doi.org/10.1111/j.1750-3841.2012.02934.x
Kay, C. D., Pereira-Caro, G., Ludwig, I. A., Clifford, M. N., & Crozier, A. (2017). Anthocyanins and flavanones are more bioavailable than previously perceived: A review of recent evidence. Annual review of food science and technology, 8, 155–180. https://doi.org/10.1146/annurev-food-030216-025636
Khan, J., Deb, P. K., Priya, S., Medina, K. D., Devi, R., Walode, S. G., & Rudrapal, M. (2021). Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules (Basel, Switzerland), 26(13), 4021. https://doi.org/10.3390/molecules26134021
Larson, A. J., Symons, J. D., & Jalili, T. (2012a). Therapeutic potential of quercetin to decrease blood pressure: Review of efficacy and mechanisms. Advances in nutrition (Bethesda, Md.), 3(1), 39–46. https://doi.org/10.3945/an.111.001271
Larson, A., Witman, M. A., Guo, Y., Ives, S., Richardson, R. S., Bruno, R. S., Jalili, T., & Symons, J. D. (2012b). Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutrition research (New York, N.Y.), 32(8), 557–564. https://doi.org/10.1016/j.nutres.2012.06.018
Lassaletta, A. D., Chu, L. M., Elmadhun, N. Y., Burgess, T. A., Feng, J., Robich, M. P., & Sellke, F. W. (2012). Cardioprotective effects of red wine and vodka in a model of endothelial dysfunction. The Journal of Surgical Research, 178(2), 586–592. https://doi.org/10.1016/j.jss.2012.06.009
Latif, R., & Alsunni, A. A. (2016). Effects of chocolate intake on oxidative stress/oxidant-antioxidant balance in medical students: A controlled clinical trial. Saudi Journal of Medicine and Medical Sciences, 4(3), 178–182. https://doi.org/10.4103/1658-631X.188260
Li, C. C., Lee, Y. C., Lo, H. Y., Huang, Y. W., Hsiang, C. Y., & Ho, T. Y. (2019). Antihypertensive effects of corn silk extract and its novel bioactive constituent in spontaneously hypertensive rats: The involvement of angiotensin-converting enzyme inhibition. Molecules (Basel, Switzerland), 24(10), 1886. https://doi.org/10.3390/molecules24101886
Liu, G., Mi, X. N., Zheng, X. X., Xu, Y. L., Lu, J., & Huang, X. H. (2014). Effects of tea intake on blood pressure: A meta-analysis of randomised controlled trials. The British journal of nutrition, 112(7), 1043–1054. https://doi.org/10.1017/S0007114514001731
Maciej, J., Schäff, C. T., Kanitz, E., Tuchscherer, A., Bruckmaier, R. M., Wolffram, S., & Hammon, H. M. (2015). Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin. Journal of Dairy Science, 98(6), 3906–3917. https://doi.org/10.3168/jds.2015-9361
Mahdavi-Roshan, M., Salari, A., Ghorbani, Z., & Ashouri, A. (2020). The effects of regular consumption of green or black tea beverage on blood pressure in those with elevated blood pressure or hypertension: A systematic review and meta-analysis. Complementary therapies in medicine, 51, 102430. https://doi.org/10.1016/j.ctim.2020.102430
Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018). Angiotensin-converting enzyme inhibitors in hypertension: To use or not to use? Journal of the American College of Cardiology, 71(13), 1474–1482. https://doi.org/10.1016/j.jacc.2018.01.058
Monteiro, M. M., França-Silva, M. S., Alves, N. F., Porpino, S. K., & Braga, V. A. (2012). Quercetin improves baroreflex sensitivity in spontaneously hypertensive rats. Molecules (Basel, Switzerland), 17(11), 12997–13008. https://doi.org/10.3390/molecules171112997
Morales-Cano, D., Menendez, C., Moreno, E., Moral-Sanz, J., Barreira, B., Galindo, P., Pandolfi, R., Jimenez, R., Moreno, L., Cogolludo, A., Duarte, J., & Perez-Vizcaino, F. (2014). The flavonoid quercetin reverses pulmonary hypertension in rats. PloS one, 9(12), e114492. https://doi.org/10.1371/journal.pone.0114492
Muñoz-Reyes, D., Morales, A. I., & Prieto, M. (2021). Transit and metabolic pathways of quercetin in tubular cells: Involvement of its antioxidant properties in the kidney. Antioxidants (Basel, Switzerland), 10(6), 909. https://doi.org/10.3390/antiox10060909
Nissa, C., Sukma, G. I., Madjid, I. J., Sidin, N. M., & Musyarrofah, M. (2022). Identifikasi potensi senyawa isoflavon dan quercetin dan perbandingan ikatan terhadap ACE (Angiotensin-Converting Enzyme) menggunakan studi in silico. Journal of Nutrition College, 11(1), 1–5. https://doi.org/10.14710/jnc.v11i1.29500
Oparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., Grassi, G., Jordan, J., Poulter, N. R., Rodgers, A., & Whelton, P. K. (2018). Hypertension. Nature Reviews. Disease primers, 4, 18014. https://doi.org/10.1038/nrdp.2018.14
Palanisamy, N., & Venkataraman, A. C. (2013). Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructose-fed hypertensive rats. The British journal of nutrition, 109(10), 1806–1812. https://doi.org/10.1017/S0007114512003819
Peluso, I., Palmery, M., & Serafini, M. (2015). Effect of cocoa products and flavanols on platelet aggregation in humans: a systematic review. Food & function, 6(7), 2128–2134. https://doi.org/10.1039/c5fo00113g
Ponder, A., Jariené, E., & Hallmann, E. (2022). The effect of storage conditions on the content of molecules in Malus domestica 'Chopin' cv. and their in vitro antioxidant activity. Molecules (Basel, Switzerland), 27(20), 6979. https://doi.org/10.3390/molecules27206979
Pruijm, M., Vollenweider, P., Mooser, V., Paccaud, F., Preisig, M., Waeber, G., Marques-Vidal, P., Burnier, M., & Bochud, M. (2013). Inflammatory markers and blood pressure: Sex differences and the effect of fat mass in the CoLaus Study. Journal of human hypertension, 27(3), 169–175. https://doi.org/10.1038/jhh.2012.12
Ravichandran, R., Rajendran, M., & Devapiriam, D. (2014). Antioxidant study of quercetin and their metal complex and determination of stability constant by spectrophotometry method. Food chemistry, 146, 472–478. https://doi.org/10.1016/j.foodchem.2013.09.080
Ried, K., Fakler, P., & Stocks, N. P. (2017). Effect of cocoa on blood pressure. The Cochrane database of systematic reviews, 4(4), CD008893. https://doi.org/10.1002/14651858.CD008893.pub3
Serban, M. C., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., Andrica, F., Ahmed, A., Aronow, W. S., Muntner, P., Lip, G. Y., Graham, I., Wong, N., Rysz, J., Banach, M., & Lipid and Blood Pressure Meta‐analysis Collaboration (LBPMC) Group (2016). Effects of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association, 5(7), e002713. https://doi.org/10.1161/JAHA.115.002713
Soares, S. S., Bekbolatova, E., Cotrim, M. D., Sakipova, Z., Ibragimova, L., Kukula-Koch, W., Giorno, T. B. S., Fernandes, P. D., Fonseca, D. A., & Boylan, F. (2019). Chemistry and pharmacology of the Kazakh Crataegus Almaatensis Pojark: An Asian herbal medicine. Antioxidants (Basel, Switzerland), 8(8), 300. https://doi.org/10.3390/antiox8080300
Somerville, V., Bringans, C., & Braakhuis, A. (2017). Polyphenols and performance: A systematic review and meta-analysis. Sports medicine (Auckland, N.Z.), 47(8), 1589–1599. https://doi.org/10.1007/s40279-017-0675-5
Sousa, A., Araújo, P., Azevedo, J., Cruz, L., Fernandes, I., Mateus, N., & de Freitas, V. (2016). Antioxidant and antiproliferative properties of 3-deoxyanthocyanidins. Food chemistry, 192, 142–148. https://doi.org/10.1016/j.foodchem.2015.06.108
Țigu, A. B., Moldovan, C. S., Toma, V. A., Farcaș, A. D., Moț, A. C., Jurj, A., Fischer-Fodor, E., Mircea, C., & Pârvu, M. (2021). Phytochemical analysis and in vitro effects of Allium fistulosum L. and Allium sativum L. extracts on human normal and tumor cell lines: A comparative study. Molecules (Basel, Switzerland), 26(3), 574. https://doi.org/10.3390/molecules26030574
Tom, E. N., Girard, C., Dimo, T., Mbafor, J. T., Berthelot, A., & Demougeot, C. (2010). Vasorelaxant effects of extracts of the stem bark of Terminalia superba Engler & Diels (Combretaceae). Journal of ethnopharmacology, 127(2), 335–340. https://doi.org/10.1016/j.jep.2009.10.036
Utari, D. A. P., Anggreni, N. P. R., Putri, P. R. J., & Laksmiani, N. P. L. (2021). Aktivitas Kuersetin sebagai Antihipertensi secara in silico. Jurnal Ilmiah Medicamento, 7(1). https://doi.org/10.36733/medicamento.v7i1.1504
Vitale, M., Masulli, M., Rivellese, A. A., Bonora, E., Cappellini, F., Nicolucci, A., Squatrito, S., Antenucci, D., Barrea, A., Bianchi, C., Bianchini, F., Fontana, L., Fornengo, P., Giorgino, F., Gnasso, A., Mannucci, E., Mazzotti, A., Nappo, R., Palena, A. P., Pata, P., … TOSCA.IT Study Group (2018). Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study. European journal of nutrition, 57(2), 679–688. https://doi.org/10.1007/s00394-016-1355-1
Vrolijk, M. F., van Essen, H., Opperhuizen, A., Bast, A., & Janssen, B. J. (2020). Haemodynamic effects of the flavonoid quercetin in rats revisited. British journal of pharmacology, 177(8), 1841–1852. https://doi.org/10.1111/bph.14955
Wang, Y., Zhang, M. S., & Liu, Y. (2013). Nebivolol treatment improves resistant arterial function and reduces ventricular hypertrophy and angiotensin II in spontaneously hypertension rats. Journal of the renin-angiotensin-aldosterone system: JRAAS, 14(2), 146–155. https://doi.org/10.1177/1470320312470580
Weh, K. M., Clarke, J., & Kresty, L. A. (2016). Cranberries and cancer: An update of preclinical studies evaluating the cancer inhibitory potential of cranberry and cranberry derived constituents. Antioxidants (Basel, Switzerland), 5(3), 27. https://doi.org/10.3390/antiox5030027
Weiss, R. J., Stapff, M., & Lin, Y. (2013). Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: A phase IV, randomized, placebo-controlled trial. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions, 13(2), 129–140. https://doi.org/10.1007/s40256-013-0010-y
West, S. G., McIntyre, M. D., Piotrowski, M. J., Poupin, N., Miller, D. L., Preston, A. G., Wagner, P., Groves, L. F., & Skulas-Ray, A. C. (2014). Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. The British journal of nutrition, 111(4), 653–661. https://doi.org/10.1017/S0007114513002912
Wick, M. J., Loomis, Z. L., Harral, J. W., Le, M., Wehling, C. A., Miller, Y. E., & Dempsey, E. C. (2016). Protection against vascular leak in neprilysin transgenic mice with complex overexpression pattern. Transgenic research, 25(6), 773–784. https://doi.org/10.1007/s11248-016-9969-x
Widiasari, S. (2018). Mekanisme inhibisi Angiotensin Converting Enzym oleh flavonoid pada hipertensi. Collaborative Medical Journal (CMJ), 1(2), 3044.
Williamson, G., Kay, C. D., & Crozier, A. (2018). The bioavailability, transport, and bioactivity of dietary flavonoids: A review from a historical perspective. Comprehensive reviews in food science and food safety, 17(5), 1054–1112. https://doi.org/10.1111/1541-4337.12351
Xie, X., Liu, Y., Perkovic, V., Li, X., Ninomiya, T., Hou, W., Zhao, N., Liu, L., Lv, J., Zhang, H., & Wang, H. (2016). Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: A bayesian network meta-analysis of randomized clinical trials. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 67(5), 728–741. https://doi.org/10.1053/j.ajkd.2015.10.011
Younes, A., Karboune, S., Liu, L., Andreani, E. S., & Dahman, S. (2023). Extraction and characterization of cocoa bean shell cell wall polysaccharides. Polymers, 15(3), 745. https://doi.org/10.3390/polym15030745
Zhuo, J. L., Ferrao, F. M., Zheng, Y., & Li, X. C. (2013). New frontiers in the intrarenal Renin-Angiotensin system: A critical review of classical and new paradigms. Frontiers in endocrinology, 4, 166. https://doi.org/10.3389/fendo.2013.00166
